We are live on ! Find out more
DB

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
-12.34%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+875.18%
AUM
$30.7B
AUM Growth
-$977M
Cap. Flow
+$3.51B
Cap. Flow %
11.43%
Top 10 Hldgs %
8.45%
Holding
3,415
New
975
Increased
649
Reduced
497
Closed
726

Sector Composition

Rank Sector Weight
1 Industrials 11.74%
2 Financials 10.8%
3 Technology 10.52%
4 Healthcare 9.15%
5 Consumer Discretionary 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPUH.WS
2526
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$11K ﹤0.01%
50,000
GSQB.WS
2527
DELISTED
G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
GSQB.WS
$11K ﹤0.01%
83,333
SVNAW
2528
DELISTED
7 Acquisition Corp Warrant
SVNAW
$11K ﹤0.01%
100,000
DTRTW
2529
DELISTED
DTRT Health Acquisition Corp. Warrant
DTRTW
$11K ﹤0.01%
175,000
MONCW
2530
DELISTED
Monument Circle Acquisition Corp. Warrant
MONCW
$11K ﹤0.01%
125,575
GNACW
2531
DELISTED
Group Nine Acquisition Corp. Warrant
GNACW
$11K ﹤0.01%
75,075
HTAQ.WS
2532
DELISTED
Hunt Companies Acquisition Corp. I Warrants, each exercisable for one Class A ordinary share at an exercise price of $11.50 per share
HTAQ.WS
$11K ﹤0.01%
75,000
GFX.WS
2533
DELISTED
Golden Falcon Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
GFX.WS
$11K ﹤0.01%
115,207
NCMI icon
2534
National CineMedia
NCMI
$256M
$10K ﹤0.01%
+1,137
New +$19.2K
IMDX
2535
Insight Molecular Diagnostics
IMDX
$145M
$10K ﹤0.01%
+540
New +$12.3K
IRAAW
2536
DELISTED
Iris Acquisition Corp Warrant
IRAAW
$10K ﹤0.01%
75,000
LCW.WS
2537
DELISTED
Learn CW Investment Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
LCW.WS
$10K ﹤0.01%
125,000
AEON.WS
2538
DELISTED
AEON Biopharma Inc
AEON.WS
$10K ﹤0.01%
66,666
LFACW
2539
DELISTED
LF Capital Acquisition Corp. II Warrants
LFACW
$10K ﹤0.01%
100,000
CORS.WS
2540
DELISTED
Corsair Partnering Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CORS.WS
$10K ﹤0.01%
33,333
EOCW.WS
2541
DELISTED
Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EOCW.WS
$10K ﹤0.01%
37,500
SVFAW
2542
DELISTED
SVF Investment Corp. Warrant
SVFAW
$10K ﹤0.01%
40,000
AKICW
2543
DELISTED
Sports Ventures Acquisition Corp. Warrant
AKICW
$10K ﹤0.01%
200,000
+105,691
+112% +$84.4K
FTVIW
2544
DELISTED
FinTech Acquisition Corp. VI Warrants
FTVIW
$10K ﹤0.01%
62,500
ACDI.WS
2545
DELISTED
Ascendant Digital Acquisition Corp. III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11. 50 per share
ACDI.WS
$10K ﹤0.01%
75,000
SCOAW
2546
DELISTED
ScION Tech Growth I Warrant
SCOAW
$10K ﹤0.01%
91,827
SHQAW
2547
DELISTED
Shelter Acquisition Corporation I Warrants
SHQAW
$10K ﹤0.01%
74,999
OEPWW
2548
DELISTED
One Equity Partners Open Water I Corp. Warrant
OEPWW
$10K ﹤0.01%
83,333
ATHX
2549
DELISTED
Athersys, Inc. Common Stock
ATHX
$10K ﹤0.01%
+1,548
New +$17.1K
AKBA icon
2550
Akebia Therapeutics
AKBA
$266M
$9K ﹤0.01%
+24,634
New +$10.3K

Similar funds

Dmitry Balyasny's Q2 2022 Portfolio in Review

As of Q2 2022, Dmitry Balyasny held 3,415 positions worth $30.7B, down 3.1% from $31.7B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.

Dmitry Balyasny deployed $3.51B of net new capital in Q2 2022, opening 975 new positions and adding to 649 existing holdings. Its largest new stake was RTX Corp: 2,351,649 shares worth $226M.

By sector, the portfolio is most concentrated in Industrials at 12% of assets, up from 11% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was PNC Financial Services, an estimated $134M trimmed.

  • Dmitry Balyasny's largest Q2 2022 buy was RTX Corp: 2,351,649 shares worth $226M.
  • Dmitry Balyasny added most to iShares Russell 2000 ETF in Q2 2022, an estimated $245M increase.
  • Dmitry Balyasny's biggest Q2 2022 reduction was PNC Financial Services, cutting an estimated $134M.
  • Dmitry Balyasny fully exited Honeywell in Q2 2022, selling an estimated $179M.
  • Dmitry Balyasny's ten largest holdings make up 8.5% of its $30.7B portfolio in Q2 2022.
  • Dmitry Balyasny opened 975 new positions and closed 726 in Q2 2022.
  • Dmitry Balyasny's portfolio value fell 3.1% quarter-over-quarter to $30.7B.

Based on Balyasny Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.